← Leaderboards
Colleen B Jonsson
University Of Tennessee Health Sci Ctr
$31,118,426
Attributed
$33,271,357
Total exposure
17
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$68,298,081 · 20
By mechanism
U19$35,826,985 · 4
UC7$9,917,525 · 2
U54$8,845,460 · 2
R01$6,444,315 · 3
G20$5,233,648 · 1
R21$1,544,239 · 3
Top collaborators
- Jennifer E. Golden6 shared
- Donghoon Chung5 shared
- Kylene Kehn-Hall1 shared
Most similar at University Of Tennessee Health Sci Ctr
Same institution · by research overlap
- Eldon E Geisert$9,914,911
- Monica M Jablonski$8,426,014
- Tonia S Rex$6,360,522
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadEfficacy StudySafetyMeetingsProgramsMonitorSmall MoleculeIn VitroVirusDrug KineticsAlphavirusInfectionStructureViralMouse ModelCollaborationsUniversitiesIn VivoCommunitiesAnimalsAnimal ModelResearch Project GrantsEvaluationChemistry
Grant awards (59)
Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery$2,428,494
UC7 · FY2025 · AI · contact PI
Impact of BDGR-49 treatment on VEEV induced neurological sequelae$452,769
R21 · FY2025 · AI
The Ferret as a model for evaluation of antiviral efficacy against Venezuelan equine encephalitis virus$423,500
R21 · FY2025 · AI · contact PI
Antiviral & Antimicrobial Countermeasures Discovery and Development Core$295,036
UC7 · FY2025 · AI · contact PI
Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery$2,385,204
UC7 · FY2024 · AI · contact PI
Antiviral & Antimicrobial Countermeasures Discovery and Development Core$1,295,544
UC7 · FY2024 · AI · contact PI
Evaluation of Optimized Lead Candidates for Encephalitic Alphaviruses in Animal Models$5,425,184
U19 · FY2023 · AI · contact PI
Center of Excellence for Encephalitic Alphavirus Therapeutics$3,021,825
U19 · FY2023 · AI · contact PI
Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery$2,297,118
UC7 · FY2023 · AI · contact PI
Antiviral & Antimicrobial Countermeasures Discovery and Development Core$1,216,129
UC7 · FY2023 · AI · contact PI
Administrative Core$55,951
U19 · FY2023 · AI · contact PI
Center of Excellence for Encephalitic Alphavirus Therapeutics$5,781,676
U19 · FY2022 · AI · contact PI
UTHSC RBL Administrative Supplement For Antiviral Discovery & Development$2,021,906
G20 · FY2022 · AI · contact PI
Administrative Core$934,276
U19 · FY2022 · AI · contact PI
Center of Excellence for Encephalitic Alphavirus Therapeutics$934,276
U19 · FY2022 · AI · contact PI
Evaluation of Optimized Lead Candidates for Encephalitic Alphaviruses in Animal Models$420,115
U19 · FY2022 · AI · contact PI
Administrative Core$165,876
U19 · FY2022 · AI · contact PI
Center of Excellence for Encephalitic Alphavirus Therapeutics$5,108,171
U19 · FY2021 · AI · contact PI
UTHSC Regional Biocontainment Laboratory: Upgrade of Facility and Building System$3,211,742
G20 · FY2021 · AI · contact PI
Evaluation of Optimized Lead Candidates for Encephalitic Alphaviruses in Animal Models$2,565,790
U19 · FY2021 · AI · contact PI
Administrative Core$199,622
U19 · FY2021 · AI · contact PI
Center of Excellence for Encephalitic Alphavirus Therapeutics$3,469,631
U19 · FY2020 · AI · contact PI
Evaluation of Optimized Lead Candidates for Encephalitic Alphaviruses in Animal Models$1,747,217
U19 · FY2020 · AI · contact PI
Administrative Core$189,620
U19 · FY2020 · AI · contact PI
Center of Excellence for Encephalitic Alphavirus Therapeutics$3,723,013
U19 · FY2019 · AI · contact PI
Evaluation of Optimized Lead Candidates for Encephalitic Alphaviruses in Animal Models$1,901,521
U19 · FY2019 · AI · contact PI
Lead Optimization of ML336, a Potent VEEV Inhibitor$594,463
R01 · FY2019 · AI
Administrative Core$183,221
U19 · FY2019 · AI · contact PI
Lead Optimization of ML336, a Potent VEEV Inhibitor$655,453
R01 · FY2018 · AI
Lead Optimization of ML336, a Potent VEEV Inhibitor$663,500
R01 · FY2017 · AI
Evolutonary Mechanisms of RNA Virus Host Switching$489,138
R01 · FY2017 · AI · contact PI
Evolutonary Mechanisms of RNA Virus Host Switching$454,268
R01 · FY2016 · AI · contact PI
Lead Optimization of ML336, a Potent VEEV Inhibitor$415,531
R01 · FY2016 · AI
X International Conference on Hemorrhagic Fever With Renal Syndrome(HFRS), Hantavirus Pulmonary Syndrome (HPS) and Hantaviruses$5,000
R13 · FY2016 · AI · contact PI
Lead Optimization of ML336, a Potent VEEV Inhibitor$447,681
R01 · FY2015 · AI
Evolutonary Mechanisms of RNA Virus Host Switching$427,809
R01 · FY2015 · AI · contact PI
Evolutonary Mechanisms of RNA Virus Host Switching$369,262
R01 · FY2014 · AI · contact PI
Administration$335,617
U54 · FY2011 · HG · contact PI
Discovery of Small Molecule Probes for Influenza NS1A$36,878
R03 · FY2011 · MH · contact PI
Administration$724,260
U54 · FY2010 · HG · contact PI
Discovery of Small Molecule Probes for Influenza NS1A$37,250
R03 · FY2010 · MH · contact PI
Southern Research Specialized Biocontainment Screening Center (SRSBSC)$3,275,776
U54 · FY2009 · HG · contact PI
Administration$892,442
U54 · FY2009 · HG · contact PI
Modeling of Hantavirus Reservoirs in Brazil$34,652
R03 · FY2009 · TW · contact PI
Southern Research Specialized Biocontainment Screening Center (SRSBSC)$2,601,540
U54 · FY2008 · HG · contact PI
Administration$1,015,825
U54 · FY2008 · HG · contact PI
Modeling of Hantavirus Reservoirs in Brazil$27,722
R03 · FY2008 · TW · contact PI
Impact of Land Cover Change on Hantavirus Ecology$8,936
R01 · FY2008 · TW · contact PI
Impact of Land Cover Change on Hantavirus Ecology$394,832
R01 · FY2007 · TW · contact PI
Modeling of Hantavirus Reservoirs in Brazil$34,652
R03 · FY2007 · TW · contact PI
Impact of Land Cover Change on Hantavirus Ecology$510,000
R01 · FY2006 · TW · contact PI
Hantavirus pathogenesis and prevention$330,981
R21 · FY2006 · AI · contact PI
Impact of Land Cover Change on Hantavirus Ecology$515,000
R01 · FY2005 · TW
Hantavirus pathogenesis and prevention$336,989
R21 · FY2005 · AI
Impact of Land Cover Change on Hantavirus Ecology$498,442
R01 · FY2004 · TW
RETROVIRAL INTEGRASE NUCLEOPROTEIN COMPLEXES$172,411
S06 · FY2002 · GM
Pilot--Biochemical principles in encapsidation pathways of human viral pathogens$0
U56 · FY2002 · CA
RETROVIRAL INTEGRASE NUCLEOPROTEIN COMPLEXES$68,672
S06 · FY2001 · GM
RETROVIRAL INTEGRASE NUCLEOPROTEIN COMPLEXES$68,672
S06 · FY2000 · GM